Axogen (AXGN) EBIT Growth (3y) (2013 - 2026)
Axogen (AXGN) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 13.06% |
| 10 | Axogen | 2.43 Bn | 2.32 Bn | 50.67 Mn | 32.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.15% |
| Mar 31, 2026 | 27.20% |
| Dec 31, 2025 | -20.33% |
| Sep 30, 2025 | 33.77% |
| Jun 30, 2025 | 30.28% |
| Mar 31, 2025 | 47.26% |
| Dec 31, 2024 | 33.45% |
| Sep 30, 2024 | 63.85% |
| Jun 30, 2024 | 60.89% |
| Mar 31, 2024 | 9.83% |
| Dec 31, 2023 | 15.92% |
| Sep 30, 2023 | -56.75% |
| Jun 30, 2023 | 5.79% |
| Mar 31, 2023 | 4.80% |
| Dec 31, 2022 | 8.91% |
| Sep 30, 2022 | 7.39% |
| Jun 30, 2022 | -1.08% |
| Mar 31, 2022 | -3.52% |
| Dec 31, 2021 | 2.94% |
| Sep 30, 2021 | -11.43% |